GlassScriptPhysician profile
Elizabeth Evans
NPI 1023699220
$1,507.11
in general payments reported to CMS, 2019-2025
8 companies · $920 in 2025
The $920 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $587 · 2025: $920.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,392 · Education: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,391.58 |
| Education | $115.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $320.20 | 2024-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Cleerly, INC. | $270.79 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Inari Medical, INC. | $162.26 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abiomed | $161.34 | 2025 | |
| Abbott Laboratories | $160.45 | 2024-2025 | Accent, Cardiomems |
| Boston Scientific Corporation | $159.98 | 2025 | Watchman Flx |
| Stryker Corporation | $156.56 | 2025 | Flowtriever |
| Medtronic, INC. | $115.53 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.